Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Nanotechnologies for the delivery of biologicals: Historical perspective and current landscape
Matilde Durán‐Lobato, Ana M. López-Estévez, Ana Sara Cordeiro, et al.
Advanced Drug Delivery Reviews (2021) Vol. 176, pp. 113899-113899
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

Oral delivery of therapeutic peptides and proteins: Technology landscape of lipid-based nanocarriers
Soheil Haddadzadegan, Farid Abedin Dorkoosh, Andreas Bernkop–Schnürch
Advanced Drug Delivery Reviews (2022) Vol. 182, pp. 114097-114097
Open Access | Times Cited: 221
Lipid Nanoparticles as Promising Carriers for mRNA Vaccines for Viral Lung Infections
Mena Hajiaghapour Asr, Fatemeh Dayani, Fatemeh Saedi Segherloo, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1127-1127
Open Access | Times Cited: 36
Cell-penetrating peptides for transmucosal delivery of proteins
Jiamin Wu, Sophie Roesger, Natalie Jones, et al.
Journal of Controlled Release (2024) Vol. 366, pp. 864-878
Closed Access | Times Cited: 14
Antithrombotic Therapy by Regulating the ROS‐Mediated Thrombosis Microenvironment and Specific Nonpharmaceutical Thrombolysis Using Prussian Blue Nanodroplets
Wenli Zhang, Junrui Wang, Zhuoyan Xie, et al.
Small (2022) Vol. 18, Iss. 15
Closed Access | Times Cited: 48
Translational aspect in peptide drug discovery and development: An emerging therapeutic candidate
Uttpal Anand, Anustup Bandyopadhyay, Niraj Kumar Jha, et al.
BioFactors (2022) Vol. 49, Iss. 2, pp. 251-269
Open Access | Times Cited: 35
Application of Nanomaterials in Early Imaging and Advanced Treatment of Atherosclerosis
Qun Zhou, Yujie Wang, Guangxiang Si, et al.
Chemical & Biomedical Imaging (2025)
Open Access
Biodistribution of 89Zr-Radiolabeled Nanoassemblies for Monoclonal Antibody Delivery Revealed through In Vivo PET Imaging
Ana M. López-Estévez, Amaia Carrascal-Miniño, Dolores Torres, et al.
ACS Omega (2025)
Open Access
Pectin-based nanoencapsulation strategy to improve the bioavailability of bioactive compounds
Thiécla Katiane Osvaldt Rosales, João Paulo Fabi
International Journal of Biological Macromolecules (2022) Vol. 229, pp. 11-21
Closed Access | Times Cited: 33
Personalized Cancer Nanomedicine: Overcoming Biological Barriers for Intracellular Delivery of Biopharmaceuticals
Ana M. López-Estévez, Philipp Lapuhs, Laura Pineiro‐Alonso, et al.
Advanced Materials (2023) Vol. 36, Iss. 14
Open Access | Times Cited: 17
Triggered protein release from calcium alginate/chitosan gastro-resistant capsules
Baojuan Zhao, Noelia Alonso, Jonathan Miras, et al.
Colloids and Surfaces A Physicochemical and Engineering Aspects (2024) Vol. 693, pp. 133998-133998
Open Access | Times Cited: 5
Nanoplatform Based Intranasal Vaccines: Current Progress and Clinical Challenges
Ziyi Bai, Dandan Wan, Tianxia Lan, et al.
ACS Nano (2024) Vol. 18, Iss. 36, pp. 24650-24681
Open Access | Times Cited: 5
Development and Nanoparticle-Mediated Delivery of Novel MDM2/MDM4 Heterodimer Peptide Inhibitors to Enhance 5-Fluorouracil Nucleolar Stress in Colorectal Cancer Cells
Francesco Merlino, Annalisa Pecoraro, Giuseppe Longobardi, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 3, pp. 1812-1824
Closed Access | Times Cited: 4
Emerging strategies for nanomedicine in autoimmunity
Ajay S. Thatte, Margaret M. Billingsley, Drew Weissman, et al.
Advanced Drug Delivery Reviews (2024) Vol. 207, pp. 115194-115194
Closed Access | Times Cited: 4
Effect of Micromixer Design on Lipid Nanocarriers Manufacturing for the Delivery of Proteins and Nucleic Acids
Enrica Chiesa, Alessandro Caimi, Marco Bellotti, et al.
Pharmaceutics (2024) Vol. 16, Iss. 4, pp. 507-507
Open Access | Times Cited: 4
Immunotherapeutic nanoparticles: From autoimmune disease control to the development of vaccines
Romina Mitarotonda, Exequiel Giorgi, Tatiane Eufrásio-da-Silva, et al.
Biomaterials Advances (2022) Vol. 135, pp. 212726-212726
Open Access | Times Cited: 25
Nanocarriers for Drug Delivery: An Overview with Emphasis on Vitamin D and K Transportation
Andreea Crintea, A Duţu, Alina Simona Şovrea, et al.
Nanomaterials (2022) Vol. 12, Iss. 8, pp. 1376-1376
Open Access | Times Cited: 24
Approved delivery strategies for biopharmaceuticals
Makhloufi Zoulikha, Zhongjian Chen, Jun Wu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 2, pp. 110225-110225
Closed Access | Times Cited: 4
Focused ion beam-scanning electron microscopy provides novel insights of drug delivery phenomena
Thilo Faber, Jason T. McConville, Alf Lamprecht
Journal of Controlled Release (2024) Vol. 366, pp. 312-327
Closed Access | Times Cited: 3
Sphingomyelin nanosystems decorated with TSP-1 derived peptide targeting senescent cells
Raneem Jatal, Sofia M. Saraiva, C. Vázquez‐Vázquez, et al.
International Journal of Pharmaceutics (2022) Vol. 617, pp. 121618-121618
Open Access | Times Cited: 19
Oral delivery of biomacromolecules by overcoming biological barriers in the gastrointestinal tract: an update
Shiyun Liu, Xiangce Wen, Xin Zhang, et al.
Expert Opinion on Drug Delivery (2023) Vol. 20, Iss. 10, pp. 1333-1347
Closed Access | Times Cited: 10
Engineered nanoparticles in non-invasive insulin delivery for precision therapeutics of diabetes
Gunjan Adwani, Sharda Bharti, Awanish Kumar
International Journal of Biological Macromolecules (2024) Vol. 275, pp. 133437-133437
Closed Access | Times Cited: 3
Extracellular vesicle-based macromolecule delivery systems in cancer immunotherapy
Hongyi Chen, Tao Sun, Chen Jiang
Journal of Controlled Release (2022) Vol. 348, pp. 572-589
Closed Access | Times Cited: 17
Nasal Nanovaccines for SARS-CoV-2 to Address COVID-19
Jialu Huang, Yubo Ding, Jingwei Yao, et al.
Vaccines (2022) Vol. 10, Iss. 3, pp. 405-405
Open Access | Times Cited: 16
Engineering hyaluronic acid-based nanoassemblies for monoclonal antibody delivery – design, characterization, and biological insights
Ana M. López-Estévez, Yixin Zhang, María Medel, et al.
Nano Research (2024) Vol. 17, Iss. 10, pp. 9111-9125
Open Access | Times Cited: 2
Nanotechnology-assisted intracellular delivery of antibody as a precision therapy approach for KRAS-driven tumors
Ana M. López-Estévez, Lucía Sanjurjo, Ángela Turrero, et al.
Journal of Controlled Release (2024) Vol. 373, pp. 277-292
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top